Bing Zhao is the Deputy Director of the institute of Organoid Technology at Nanchang University. Previously he was a Tenured Professor in the School of Life Sciences at Fudan University in Shanghai, as well as having post-doctoral research positions at the Cincinnati Children's Hospital Medical Centre in the US. Professor Zhao completed his undergraduate study at the China Agricultural University in Beijing, before completing his PhD at the Tsinghua University School of Life Sciences.

Professor Zhao conducts research on the mechanisms of tissue stem cell fate determination and innovative strategies for organoid cultivation. In the recent five years, he published a series of research papers as the corresponding author in renowned journals including Advanced Science, Nature Communications, Science Advances, Protein & Cell, and Genome Biology. These contributions significantly advance the fields of regenerative biology and organoid technology. The representative findings have been highlighted in interviews by Nature News, featured on the official Nature website, and recognized in prestigious review journals such as Nature Reviews Molecular Cell Biology and Nature Reviews Gastroenterology & Hepatology. He is awarded the National Excellent Young Scientist of China and granted as a Chief Scientist of the National Key Research and Development Program of China.

Topic title: Application of human organoids in disease modeling for translational medicine

Abstract:

The burgeoning advancements in organoid technology have facilitated the feasibility of generating human organs in vitro. This development catalyzes a profound paradigm shift in the realms of biomedical research, pharmaceutical development, and precision medicine. In this presentation, the speaker offers insights from their research group, elucidating the practical merits of employing human organoid models in the investigation of genetic and infectious disease modeling, translational medicine, and drug discovery. Furthermore, the speaker delineates prospective directions for the research and industrial development of organoid technology.